Nuevocor

Series-B+
nuevocor.com Biotech & Healthcare
Total Funding $45M
Latest Round $45M Series-B+
Last Announced May 6, 2025
Investors Undisclosed
Decision Makers 6 Verified

About Nuevocor

Nuevocor is a IND-stage biotech focused on treating genetic cardiomyopathies by addressing their underlying mechanical defects

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website nuevocor.com
Domain Registered Date Feb 3, 2021

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $45,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    Website domain registered

    nuevocor.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Nuevocor.

Funding History

1 Round
Series-B+ · May 6, 2025

Founders & Leadership

3

Brian Burke

Co-Founder and Advisor

Work email & phone locked Unlock →

Colin Stewart

Co-Founder and Advisor

Work email & phone locked Unlock →

Mark Kay

Co-Founder and Advisor

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts